Expression of GSK3B in peripheral blood of patients with Parkinson's disease

被引：1

作者：

Filatova, E. V. ^{[1
]}

Shadrina, M. I. ^{[1
]}

Karabanov, A. V. ^{[2
]}

Slominsky, P. A. ^{[1
]}

Illarioshkin, S. N. ^{[2
]}

Ivanova-Smolenskaya, I. A. ^{[2
]}

Limborska, S. A. ^{[1
]}

机构：

[1] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia

[2] Russian Acad Med Sci, Ctr Neurol Sci, Moscow 125367, Russia

来源：

MOLECULAR BIOLOGY | 2011年 / 45卷 / 03期

基金：

俄罗斯基础研究基金会;

关键词：

expression level; GSK3B; Parkinson's disease; real-time polymerase chain reaction; TAU-PROTEIN; DOPAMINE; BRAIN; GLYCOGEN-SYNTHASE-KINASE-3; LYMPHOCYTES; GENE;

D O I：

10.1134/S0026893311020063

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Parkinson's disease (PD) is the second most common progressive neurodegenerative disorder characterized by the degeneration of dopaminergic neurons. Detecting changes in gene expression in untreated de novo patients with PD is important for understanding the disease pathogenesis and for identifying biomarkers of the preclinical stage of PD. In this study, the expression of the glycogen synthase kinase-3 beta gene (GSK3B) was investigated in the peripheral blood of several groups of neurological patients using reverse transcription reaction and real-time PCR. Our results suggest that the GSK3B expression level cannot serve as a biomarker for early stages of PD.

引用

页码：417 / 420

页数：4

共 50 条

[31] THE POTENTIAL OF GSK3B INHIBITORS AS NOVEL THERAPEUTICS FOR GVHD
Klamer, G.
O'Brien, T. A.
Dolnikov, A.
EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : S22 - S23
[32] Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease
Zhang, Zhuo
Xie, Xin
Cai, Ying
Liu, Peipei
Liu, Shoufeng
Chen, Rongjie
Wang, Jin
Wang, Yue
Zhao, Yanan
Zhu, Zhizhong
Zhang, Xinyuan
Wu, Jialing
PARKINSONISM & RELATED DISORDERS, 2023, 116
[33] Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients
Talib, L. L.
Hototian, S. R.
Joaquim, H. P. G.
Forlenza, O. V.
Gattaz, W. F.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2015, 265 (08) : 701 - 706
[34] Increased Glycogen Synthase Kinase-3B (GSK3B) Expression in Platelets of First Onset Psychosis Non-affective Patients
Joaquim, Helena P. G.
Talib, Leda L.
van de Bilt, Martinus Th
Zanetti, Marcus V.
Busatto, Geraldo
Serpa, Mauricio H.
Gattaz, Wagner F.
BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 78S - 78S
[35] Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma
Zhu, Ming-Chuang
Zhang, Yan-Hong
Xiong, Peng
Fan, Xiao-Wu
Li, Guo-Liang
Zhu, Min
CANCER GENE THERAPY, 2022, 29 (11) : 1761 - 1772
[36] Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma
Ming-Chuang Zhu
Yan-Hong Zhang
Peng Xiong
Xiao-Wu Fan
Guo-Liang Li
Min Zhu
Cancer Gene Therapy, 2022, 29 : 1761 - 1772
[37] SELECTIVE REGULATION OF GSK3B IN CAMKII NEURONS IN THE PREFRONTAL CORTEX
Bledsoe, D.
Gottlieb, S.
Van der Vaart, A.
Miles, M. F.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 182A - 182A
[38] Dopamine decreases SNCA gene expression in peripheral blood lymphocytes from Parkinson's disease patients in vitro
Lavrinova, A.
Litusova, E.
Milyukhina, I.
Nikolaev, M.
Pchelina, S.
Emelyanov, A.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1033 - S1033
[39] Expression Profile of circRNA In Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes
Bougea, A.
Ravanidis, S.
Simistiras, A.
Maniati, M.
Koros, C.
Simitsi, A.
Stefanis, L.
Doxakis, E.
MOVEMENT DISORDERS, 2023, 38 : S63 - S63
[40] β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression
Wang, Ruoyu
Tang, Dan
Ou, Longyun
Jiang, Jiacheng
Wu, Yu-nan
Tian, Xuefei
HUMAN CELL, 2024, 37 (04) : 1156 - 1169

← 1 2 3 4 5 →